PIXUVRI (PIXANTRONE)
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Dec 2016)
What this means for you
This application is over — abandoned 12 Dec 2016. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85684304
- Mark type
- Design + words
- Filed
- 23 Jul 2012
- Published for opposition
- 10 Sept 2013
- Abandoned
- 12 Dec 2016
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of immunological and inflammatory diseases and for use in chemotherapy treatment made in significant part of pixantrone; pharmaceutical preparations used for the treatment of cancer made in significant part of pixantrone
Owner
- CTI BIOPHARMA CORP., SEATTLE, WA, US
- Cell Therapeutics, Inc., Seattle, WA, US
- Cell Therapeutics, Inc., Seattle, WA, US
Prior registrations
Prosecution history
- 12 Dec 2016 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 12 Dec 2016 — ABANDONMENT - NO USE STATEMENT FILED
- 06 May 2016 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 May 2016 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Apr 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Apr 2016 — SOU EXTENSION 5 GRANTED
- 04 Apr 2016 — SOU EXTENSION 5 FILED
- 04 Apr 2016 — SOU TEAS EXTENSION RECEIVED
- 30 Oct 2015 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Oct 2015 — SOU EXTENSION 4 GRANTED
- 19 Oct 2015 — SOU EXTENSION 4 FILED
- 19 Oct 2015 — SOU TEAS EXTENSION RECEIVED
- 17 Apr 2015 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Apr 2015 — SOU EXTENSION 3 GRANTED
- 14 Apr 2015 — SOU EXTENSION 3 FILED